Aligos Therapeutics, Inc. (ALGS)

Aligos Therapeutics Revenue

Aligos Therapeutics had revenue of $2.83M in the quarter ending March 31, 2026, with 809.97% growth. This brings the company's revenue in the last twelve months to $4.71M, up 43.88% year-over-year. In the year 2025, Aligos Therapeutics had annual revenue of $2.19M, down -44.59%.

• Revenue (ttm): $4.71M
• Revenue Growth: +43.88%
• P/S Ratio: 7.50
• Revenue / Employee: $57,378
• Employees: 82
• Market Cap: 35.27M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.19M	-1.76M	-44.59%
Dec 31, 2024	3.95M	-11.58M	-74.60%
Dec 31, 2023	15.53M	1.62M	11.66%
Dec 31, 2022	13.91M	9.55M	219.04%
Dec 31, 2021	4.36M	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 5, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 30, 2026

Data Sources Report a data error